Tiziana Life Sciences (TLSA) Short-term Investments (2022 - 2024)

Tiziana Life Sciences (TLSA) has reported Short-term Investments for 3 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2024.

• Quarterly Short-term Investments fell 2081.25% year-over-year to -$1.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$1.6 million (down 2081.25% YoY) and the FY2023 annual result came in at $402000.0, down 53.74% from the prior year.
• Short-term Investments eased to -$1.6 million in Q2 2024 per TLSA's latest filing, from -$402000.0 in the prior quarter.
• Over the last five years, Short-term Investments for TLSA reached as high as $869000.0 in Q4 2022 and fell as low as -$1.6 million in Q2 2024.
• A 3-year average of -$259500.0 and a median of -$161000.0 in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2023 — Short-term Investments sank 146.26% — and 2024, when it tumbled 2081.25%.
• Year by year, Short-term Investments stood at $869000.0 in 2022, then plunged by 146.26% to -$402000.0 in 2023, then sank by 294.28% to -$1.6 million in 2024.
• According to Business Quant data, Short-term Investments over the past three periods registered -$1.6 million, -$402000.0, and $80000.0 for Q2 2024, Q4 2023, and Q2 2023 respectively.